The DNA damage response (DDR) pathway is an important mode of regulation of NKG2D ligands in both mouse and human cells and appears to act largely post-transcriptionally [32,63,64].
AID deregulation in Abelson murine leukemia virus-infected cells induced the DDR and the expression of NKG2D ligands [65].
The HIV Vpr protein activates the ATR kinase and the DDR leading to the expression of NKG2D ligands [66].
The HIV Vif protein degrades the antiviral host protein APOBEC3G, preventing the deamination of cytosine residues, the DDR and the expression of NKG2D ligands [67].
Many different microRNAs have been implicated in NKG2D ligands regulation, including miR-17-5p, miR-20a, miR-34a, miR-34c, miR-93, miR-106b, miR-373, and miR-520 [68].
PI3K signaling was implicated in the induction of RAE-1 [69].
The oncogene RAS induces the expression of RAE-1α and RAE- 1β in mouse cells as well as ULBP1-3 in human cells [70].
The adenovirus E1A oncogene protein induces Raet1 mRNAs and the RAE-1 protein [71].
The RNA-binding protein RBM4 supports ULBP1 expression by facilitating proper splicing of the first two exons of the primary transcript [62].